Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade
Source: SeekingAlpha
2025-10-29 07:30:53 ET
Clover Health Investments, Corp. (CLOV), has been gaining momentum lately with Q3 earnings right around the corner. Since my last coverage post-Q2 earnings, the stock is up 52%, mainly driven by a 21% rally over the past 5 trading days, despite its latest star rating downgrade earlier this month....
Read the full article on Seeking Alpha
For further details see:
Clover Health: Clinical Excellence To Fuel SaaS Growth Beyond The Star Downgrade
Clover Health Investments Corp.
NASDAQ: CLOV
CLOV Trading
0.25% G/L:
$1.975 Last:
2,238,509 Volume:
$2.01 Open:
CLOV Latest News
March 10, 2026 08:30:00 am
UPDATED - Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
March 04, 2026 08:30:00 am
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
February 26, 2026 04:05:00 pm
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
CLOV Stock Data
$1,097,940,867
499,111,001
4.37%
60
N/A
Medical Service Plans
Healthcare
US
